In compliance with the relevant provisions of Regulation 42 read with such other applicable provisions of the Listing Regulations subject to the provisions of the NCLT Order dated December ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cian Healthcare is undergoing a major share capital restructuring as part of its insolvency resolution plan approved by the NCLT Mumbai on December 18, 2025. The company has set January 16, 2026 as the record date. The erstwhile promoters' entire shareholding of 67,74,897 shares (27.10% of paid-up capital) will be cancelled to zero with no consideration, as their liquidation value is NIL. Public shareholders' existing 1,82,20,867 shares (72.90%) will also be cancelled, and in exchange they will receive only 12,50,000 fresh equity shares in proportion to their current holdings. This effectively means public shareholders retain roughly 6.86% of their pre-restructuring share count, with the balance 93.14% being extinguished.
This is severely value-destructive for existing shareholders. Promoters are completely wiped out with no payout, and public shareholders face a ~93% reduction in their share count, which will likely translate into a sharp drop in the stock price post the record date. The restructuring is a typical outcome under the IBC framework where the company's capital base is reset to make room for resolution applicants/financial creditors.